Oncolytics Biotech (TSE:ONC) will be posting its quarterly earnings results before the market opens on Monday, November 12th. Analysts expect Oncolytics Biotech to post earnings of C($0.29) per share for the quarter.

ONC opened at C$3.51 on Friday. Oncolytics Biotech has a twelve month low of C$3.41 and a twelve month high of C$10.65.

ILLEGAL ACTIVITY WARNING: “Oncolytics Biotech (ONC) to Release Earnings on Monday” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another website, it was stolen and republished in violation of United States & international copyright & trademark legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/oncolytics-biotech-onc-to-release-earnings-on-monday/2599192.html.

Oncolytics Biotech Company Profile

Oncolytics Biotech Inc, a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing REOLYSIN, an immuno-oncology viral-agent that comprises three programs: chemotherapy combinations to trigger selective tumor lysis; immune modulator combinations to facilitate innate immune responses; and immuno-therapy combinations to produce adaptive immune responses.

Recommended Story: NASDAQ

Earnings History for Oncolytics Biotech (TSE:ONC)

Receive News & Ratings for Oncolytics Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncolytics Biotech and related companies with MarketBeat.com's FREE daily email newsletter.